1. Home
  2. ANVS vs ORMP Comparison

ANVS vs ORMP Comparison

Compare ANVS & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • ORMP
  • Stock Information
  • Founded
  • ANVS 2008
  • ORMP 2002
  • Country
  • ANVS United States
  • ORMP United States
  • Employees
  • ANVS N/A
  • ORMP N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANVS Health Care
  • ORMP Health Care
  • Exchange
  • ANVS Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • ANVS 92.6M
  • ORMP 90.7M
  • IPO Year
  • ANVS 2020
  • ORMP N/A
  • Fundamental
  • Price
  • ANVS $2.58
  • ORMP $2.47
  • Analyst Decision
  • ANVS Strong Buy
  • ORMP Hold
  • Analyst Count
  • ANVS 6
  • ORMP 1
  • Target Price
  • ANVS $31.40
  • ORMP N/A
  • AVG Volume (30 Days)
  • ANVS 599.3K
  • ORMP 435.6K
  • Earning Date
  • ANVS 03-31-2025
  • ORMP 03-05-2025
  • Dividend Yield
  • ANVS N/A
  • ORMP N/A
  • EPS Growth
  • ANVS N/A
  • ORMP N/A
  • EPS
  • ANVS N/A
  • ORMP 0.11
  • Revenue
  • ANVS N/A
  • ORMP N/A
  • Revenue This Year
  • ANVS N/A
  • ORMP N/A
  • Revenue Next Year
  • ANVS N/A
  • ORMP N/A
  • P/E Ratio
  • ANVS N/A
  • ORMP $22.57
  • Revenue Growth
  • ANVS N/A
  • ORMP N/A
  • 52 Week Low
  • ANVS $2.44
  • ORMP $2.00
  • 52 Week High
  • ANVS $20.00
  • ORMP $3.67
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 18.79
  • ORMP 60.22
  • Support Level
  • ANVS $2.44
  • ORMP $2.16
  • Resistance Level
  • ANVS $5.50
  • ORMP $3.09
  • Average True Range (ATR)
  • ANVS 0.32
  • ORMP 0.14
  • MACD
  • ANVS -0.17
  • ORMP 0.03
  • Stochastic Oscillator
  • ANVS 5.22
  • ORMP 36.08

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: